BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21303982)

  • 1. Noncytotoxic differentiation treatment of renal cell cancer.
    Negrotto S; Hu Z; Alcazar O; Ng KP; Triozzi P; Lindner D; Rini B; Saunthararajah Y
    Cancer Res; 2011 Feb; 71(4):1431-41. PubMed ID: 21303982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.
    Alcazar O; Achberger S; Aldrich W; Hu Z; Negrotto S; Saunthararajah Y; Triozzi P
    Int J Cancer; 2012 Jul; 131(1):18-29. PubMed ID: 21796622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
    Shang D; Han T; Xu X; Liu Y
    Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia.
    Ng KP; Ebrahem Q; Negrotto S; Mahfouz RZ; Link KA; Hu Z; Gu X; Advani A; Kalaycio M; Sobecks R; Sekeres M; Copelan E; Radivoyevitch T; Maciejewski J; Mulloy JC; Saunthararajah Y
    Leukemia; 2011 Nov; 25(11):1739-50. PubMed ID: 21701495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
    Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
    Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
    Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers.
    Cooper SJ; von Roemeling CA; Kang KH; Marlow LA; Grebe SK; Menefee ME; Tun HW; Colon-Otero G; Perez EA; Copland JA
    Mol Cancer Ther; 2012 Oct; 11(10):2105-15. PubMed ID: 22826467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
    Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
    Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apigenin inhibits renal cell carcinoma cell proliferation.
    Meng S; Zhu Y; Li JF; Wang X; Liang Z; Li SQ; Xu X; Chen H; Liu B; Zheng XY; Xie LP
    Oncotarget; 2017 Mar; 8(12):19834-19842. PubMed ID: 28423637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
    Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRM1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth.
    Inoue H; Kauffman M; Shacham S; Landesman Y; Yang J; Evans CP; Weiss RH
    J Urol; 2013 Jun; 189(6):2317-26. PubMed ID: 23079374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of nuclear factor kappa B in renal cell carcinoma.
    Morais C; Gobe G; Johnson DW; Healy H
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1537-49. PubMed ID: 21854869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
    Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
    Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
    Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
    Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent.
    Xiong Z; Zang Y; Zhong S; Zou L; Wu Y; Liu S; Fang Z; Shen Z; Ding Q; Chen S
    Oncotarget; 2017 May; 8(18):30151-30161. PubMed ID: 28404914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decitabine maintains hematopoietic precursor self-renewal by preventing repression of stem cell genes by a differentiation-inducing stimulus.
    Hu Z; Negrotto S; Gu X; Mahfouz R; Ng KP; Ebrahem Q; Copelan E; Singh H; Maciejewski JP; Saunthararajah Y
    Mol Cancer Ther; 2010 Jun; 9(6):1536-43. PubMed ID: 20501800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A demethylating agent enhances chemosensitivity to vinblastine in a xenograft model of renal cell carcinoma.
    Iwata H; Sato H; Suzuki R; Yamada R; Ichinomiya S; Yanagihara M; Okabe H; Sekine Y; Yano T; Ueno K
    Int J Oncol; 2011 Jun; 38(6):1653-61. PubMed ID: 21479360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.
    Liu X; Zhang D; Hao Y; Liu Q; Wu Y; Liu X; Luo J; Zhou T; Sun B; Luo X; Xu J; Wang Q; Yang Z; Li L
    Cell Physiol Biochem; 2018; 46(6):2517-2531. PubMed ID: 29742507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth.
    Wettersten HI; Landesman Y; Friedlander S; Shacham S; Kauffman M; Weiss RH
    PLoS One; 2014; 9(12):e113867. PubMed ID: 25461627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
    Wu WS; Chien CC; Chen YC; Chiu WT
    PLoS One; 2016; 11(8):e0160484. PubMed ID: 27483435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.